Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Madrigal Pharmaceuticals (Nasdaq: MDGL) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on June 11, 2024. The company will present at 8:40 A.M. ET, with the presentation webcast live on Madrigal’s Investor Relations Events page. A replay of the webcast will be available post-event. This participation reflects Madrigal's engagement with key industry stakeholders and potential investors.

Positive

• Participation in a prestigious event like the Goldman Sachs 45th Annual Global Healthcare Conference boosts Madrigal’s visibility and credibility in the healthcare sector.
• The live webcast allows for broader investor access and engagement, potentially increasing investor confidence.

Negative

• The PR does not disclose any new clinical data or significant financial updates, which may be considered a lack of substantial news to impact the stock positively.
• Investors seeking immediate actionable information might be disappointed as the announcement is more about participation rather than concrete business developments.

CONSHOHOCKEN, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in the Goldman Sachs 45^th Annual Global Healthcare Conference on Tuesday, June 11, 2024, and will present at 8:40 A.M. ET.

The presentation will be webcast live and may be accessed here or by visiting Madrigal’s website’s Investor Relations Events page. A replay of the webcast will be available after the event.

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of NASH. For more information, visit www.madrigalpharma.com.

Investor Contact
Tina Ventura, Madrigal Pharmaceuticals, Inc., IR@madrigalpharma.com

Media Contact
Christopher Frates, Madrigal Pharmaceuticals, Inc., media@madrigalpharma.com

FAQ

When will Madrigal Pharmaceuticals present at the Goldman Sachs 45th Annual Global Healthcare Conference?

Madrigal Pharmaceuticals will present on June 11, 2024, at 8:40 A.M. ET.

Where can I watch Madrigal Pharmaceuticals' presentation at the Goldman Sachs 45th Annual Global Healthcare Conference?

The presentation will be webcast live and can be accessed on Madrigal’s Investor Relations Events page.

Will a replay of Madrigal Pharmaceuticals' presentation be available?

Yes, a replay of the webcast will be available after the event.

What is the stock symbol for Madrigal Pharmaceuticals?

The stock symbol for Madrigal Pharmaceuticals is MDGL.

What is the significance of Madrigal Pharmaceuticals participating in the Goldman Sachs 45th Annual Global Healthcare Conference?

Participation in such a prestigious event enhances Madrigal's visibility among key industry stakeholders and potential investors.